Perampanel + Placebo comparator

Phase 3Completed

1 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Seizure Disorder Generalized Tonic Clonic

Conditions

Seizure Disorder Generalized Tonic Clonic

Trial Timeline

Sep 1, 2011 → Nov 1, 2015

NCT ID

NCT01393743

About Perampanel + Placebo comparator

Perampanel + Placebo comparator is a phase 3 stage product being developed by Eisai for Seizure Disorder Generalized Tonic Clonic. The current trial status is completed. This product is registered under clinical trial identifier NCT01393743. Target conditions include Seizure Disorder Generalized Tonic Clonic.

What happened to similar drugs?

7 of 20 similar drugs in Seizure Disorder Generalized Tonic Clonic were approved

Approved (7) Terminated (3) Active (12)

🔄E2007EisaiPhase 3

🔄perampanel + perampanel + perampanel + PlaceboEisaiPhase 3

🔄Zonisamide + PlaceboEisaiPhase 3

🔄E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3

🔄Perampanel + PlaceboEisaiPhase 3

🔄E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3

✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01393743	Phase 3	Completed	Sep 1, 2011	Nov 1, 2015	Seizure Disorder Generalized Tonic Clonic

Competing Products

20 competing products in Seizure Disorder Generalized Tonic Clonic

See all competitors

Product	Company	Stage	Hype Score
E2007	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
perampanel + perampanel + perampanel + Placebo	Eisai	Phase 3	40
perampanel	Eisai	Phase 2	35
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide	Eisai	Pre-clinical	26
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Phase 3	40
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Adjunctive Zonisamide + Replacement with Zonisamide	Eisai	Approved	43
Fycompa	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
Fycompa	Eisai	Pre-clinical	26
Rufinamide	Eisai	Phase 3	32
Eslicarbazepine Acetate tablets	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26
Perampanel	Eisai	Approved	43
Perampanel + Perampanel	Eisai	Pre-clinical	26